Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, GlycoMimetics Inc (NASDAQ: GLYC) closed at $0.14 down -6.09% from its previous closing price of $0.15. In other words, the price has decreased by -$6.09 from its previous closing price. On the day, 0.71 million shares were traded. GLYC stock price reached its highest trading level at $0.1519 during the session, while it also had its lowest trading level at $0.1406.
Ratios:
For a deeper understanding of GlycoMimetics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.48 and its Current Ratio is at 5.48. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 22, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $12.
Jefferies Upgraded its Hold to Buy on November 12, 2021, whereas the target price for the stock was revised from $3 to $4.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 08 ’24 when Invus Public Equities, L.P. sold 260,873 shares for $0.19 per share. The transaction valued at 50,009 led to the insider holds 6,317,565 shares of the business.
Invus Public Equities, L.P. sold 61,488 shares of GLYC for $11,197 on Aug 07 ’24. The 10% Owner now owns 6,578,438 shares after completing the transaction at $0.18 per share. On Aug 05 ’24, another insider, Invus Public Equities, L.P., who serves as the 10% Owner of the company, sold 164,523 shares for $0.19 each. As a result, the insider received 30,996 and left with 6,695,658 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GLYC now has a Market Capitalization of 9253454 and an Enterprise Value of -12683829. For the stock, the TTM Price-to-Sale (P/S) ratio is 925.29 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at -1268.383 whereas that against EBITDA is 0.311.
Stock Price History:
Over the past 52 weeks, GLYC has reached a high of $3.53, while it has fallen to a 52-week low of $0.15. The 50-Day Moving Average of the stock is -16.74%, while the 200-Day Moving Average is calculated to be -89.55%.
Shares Statistics:
For the past three months, GLYC has traded an average of 1.08M shares per day and 525040 over the past ten days. A total of 64.39M shares are outstanding, with a floating share count of 59.08M. Insiders hold about 8.38% of the company’s shares, while institutions hold 35.46% stake in the company. Shares short for GLYC as of 1726185600 were 1821987 with a Short Ratio of 1.69, compared to 1723680000 on 2312921. Therefore, it implies a Short% of Shares Outstanding of 1821987 and a Short% of Float of 4.0700004.
